These results suggest that maintaining MIST1 activity in Kras-expressing acinar cells can partially mitigate the transformation activity of oncogenic KRAS. Future therapeutics that target Mist1 transcriptional networks may show promising efficacy in combating pancreatic cancer.DiRenzo, Daniel Michael...